Medical Device import/export and registration regulatory requirements reduction in Israel

Regulatory Reform for Medical Device Registration and Import in Israel

The Bottom Line for Medical Device Manufacturers and Importers:
The Ministry of Health (IMOH) Medical Equipment Reform is a seismic shift designed to slash bureaucratic hurdles and accelerate market entry for innovative healthcare technologies. By moving toward a risk-based classification system and allowing for self-declaration and 60-day accelerated tracks the IMOH is transforming Israel into a more efficient and competitive market. For manufacturers this means a direct route to market entry that echoes efficiency and cost-effectiveness provided you have the expert oversight to manage these new self-declaration responsibilities.

In a groundbreaking move the Ministry of Health (IMOH) introduced the Medical Equipment Reform in its AMAR division. This new reform for medical devices redefines the landscape of medical device registration in Israel and medical device importing or exporting to the Israeli market. This bold reform is a resolute step towards slashing bureaucratic complexities and ushering in a regulatory environment primed for growth.

What is the AMAR division in the IMOH

In the realm of medical device operations Israel’s focal regulatory entity is the Medical Device Division of the Ministry of Health famously known as AMAR. This division holds the reins of medical device registration, submissions, oversight, and meticulous control spanning manufacturing, assembly, sterilization, importation, and marketing within the State of Israel.

At its core AMAR orchestrates diverse import permits for medical devices while vigilantly monitoring every facet of the marketing journey. This body is equally renowned for its role in disseminating crucial documents, guidelines, and procedures. These resources serve as beacons of guidance for the import process of medical devices crafted abroad and destined for the Israeli market.

New Regulations for Medical Device Registration and Import to Israel

At the heart of this paradigm shift lies a monumental reduction in medical device registration timelines poised to revolutionize the import and export landscape. Underpinned by a risk-based classification system the IMOH reform presents an innovative avenue for swift approvals.

Below are the main changes per medical device classification:

Medical Device Class	New Regulatory Requirements
Class I	Low-risk medical devices will now be granted immediate approval via a self-declaration process.
Class II	For devices with moderate risk a rapid 60-day accelerated track awaits contingent upon registration and recognition by acknowledged nations like the USA and Europe.
Class III	Will remain unchanged in the registration process—for example stents for arteries and the like.
Renewals	For all types of medical equipment and devices it will be possible to renew the notification based on the countries of Europe and the USA.

Regarding changes there will be a distinction between a change that is not essential and a change that is essential through the adoption of the European Union directives (MDR). A change that is not essential will be recorded in the declaration or notification. For registering a substantial change a Service Level Agreement (SLA) is established to ensure predictable timelines.

How New Medical Device Registration in Israel will look after Reform

As the tides of responsibility shift manufacturers and importers find themselves at the helm of compliance galvanized by streamlined processes. The IMOH reform transcends bureaucratic hurdles and paves a direct route to market entry marked by efficiency and timely access to groundbreaking medical solutions. This seismic reform dovetails seamlessly with Israel’s commitment to fostering a competitive market ecosystem.

As the annual medical equipment market nears 9 billion NIS the projected savings of over 90 million NIS annually heralds an era of affordability and innovation. This promises a diverse array of innovative medical devices for Israeli consumers. Amidst the whirlwind of this transformation Eran Yona emerges as your unwavering partner. With a resolute focus on medical device registration in Israel and facilitating importing and exporting endeavors we stand poised to guide manufacturers through this regulatory evolution.

Frequently Asked Questions

What qualifies as an immediate approval for Class I devices?
Under the new reform low-risk devices no longer require a lengthy AMAR review. The importer or manufacturer can submit a self-declaration of compliance to receive immediate approval for distribution.

How does the 60 day accelerated track work for Class II devices?
If the device is already registered and recognized by the FDA or within the European Union it enters a fast-track process that guarantees a response or approval within 60 days.

What is the impact of the MDR adoption on essential changes?
By adopting MDR directives the IMOH now distinguishes between non-essential changes recorded via notification and substantial changes that require a formal regulatory technical file submission and follow a specific SLA.